INFLUENCE OF AGING ON MITOCHONDRIAL GENE EXPRESSION FOLLOWING TRAUMA-HEMORRHAGE

描述（由申请人提供）：在理解衰老过程如何改变健康和疾病中的线粒体基因表达方面存在根本性差距。众所周知，创伤失血性休克后，尽管进行了液体复苏，心血管功能仍明显下降。由于线粒体功能在这些条件下也被抑制，因此关于休克后线粒体基因表达中与年龄相关的改变的信息将有助于理解衰老和线粒体基因在心脏损伤中的作用，并可能设计适当的干预策略。我们的长期目标是确定休克和创伤后心脏线粒体基因年龄相关改变的分子基础。我们的中心假设是创伤-出血性休克导致心脏中线粒体基因表达的年龄特异性病理学改变，这可以在使用线粒体基因芯片的实验模型中确定。本研究的目的是建立一种啮齿类动物线粒体基因芯片，并利用该芯片检测创伤失血性休克大鼠心肌线粒体基因表达的变化。将通过以下三个具体目标实现这一目标：（1）开发啮齿动物线粒体基因芯片RoMITOchip，以确定创伤-出血性休克实验模型中与年龄相关的线粒体基因表达变化，（2）使用（i）经受缺氧和常氧条件的大鼠和小鼠心肌细胞的体外模型验证RoMITOchip，（ii）线粒体功能固有改变的小鼠;（3）使用RoMITOchip确定衰老在正常大鼠和创伤-失血性休克大鼠模型中线粒体基因表达谱中的作用。线粒体基因组上的少量基因未在Affyellow大鼠或小鼠基因芯片中呈现。RoMITOchip是我们的重点阵列，将包括来自核基因组的基因，这些基因有助于线粒体结构和功能，以及线粒体DNA上的基因，统称为线粒体基因。我们将大鼠和小鼠的线粒体基因整合到单基因芯片RoMITOchip中，并计划使用该工具来确定年轻成年和老年大鼠创伤出血后心脏线粒体基因表达的变化。因此，拟议中的研究与NIH的使命的一部分有关，该使命涉及开发可能有助于减轻人类疾病负担的基础知识。这项研究将在创伤出血的衰老和心功能障碍的背景下具有重要意义，因为它有望开发一种工具，并用于阐明创伤出血后衰老心脏中的线粒体基因表达谱。Narrative 该项目的成功实现将阐明创伤出血后心脏线粒体基因表达的年龄相关变化，作为该项目的一部分，将开发的基因芯片将在衰老和心血管研究中有更广泛的用途。

DESCRIPTION (provided by applicant): There is a fundamental gap in understanding how aging process alters mitochondrial gene expression in health and disease. It is well known that cardiovascular functions are markedly depressed following trauma-hemorrhagic shock despite fluid resuscitation. Since mitochondrial functions are also depressed under those conditions, information concerning the age related alterations in mitochondrial gene expression after shock will be useful in understanding the role of aging and mitochondrial genes in cardiac impairment and potentially devising appropriate intervention strategies. Our long-term goal is to determine the molecular basis of the age-associated alteration of cardiac mitochondrial genes following shock and trauma. Our central hypothesis is that trauma-hemorrhagic shock leads to age- specific pathological alterations in the mitochondrial gene expression in the heart, which can be determined in an experimental model using a mitochondrial gene chip. The objective of this proposal is to develop and validate a rodent mitochondrial gene chip and use it to determine the alteration in the cardiac mitochondrial gene expression in a rat model of trauma-hemorrhagic shock. This objective will be achieved by pursuing the following three specific aims: (1) develop a rodent mitochondrial gene chip, RoMITOchip, to determine age related mitochondrial gene expression changes in an experimental model of trauma-hemorrhagic shock, ( 2) validate the RoMITOchip using (i)in vitro models of rat and mouse cardiomyocytes subjected to hypoxic and normoxic conditions, (ii) mice with inherent alteration in mitochondrial function; and (3) determine the role of aging in mitochondrial gene expression profile in the normal rat and a rat model of trauma-hemorrhagic shock using RoMITOchip. The small number of genes on the mitochondrial genome is not represented in the Affymetrix rat or mouse GeneChip. The RoMITOchip, our focused array, will include genes from the nuclear genome that contribute to the mitochondrial structure and function as well as the genes on the mitochondrial DNA, together called as mitochondrial genes. We will incorporate mitochondrial genes of the rat and the mouse into the single gene chip, RoMITOchip, and plan to use this tool to determine cardiac mitochondrial gene expression changes following trauma-hemorrhage in the young adult and aged rats. Thus the proposed research is relevant to that part of NIH's mission that pertains to developing fundamental knowledge that will potentially help to reduce the burdens of human disease. The proposed research will be significant in the context of aging and cardiac dysfunction in trauma-hemorrhage, because it is expected to develop a tool and use it to elucidate the mitochondrial gene expression profile in the aging heart following trauma-hemorrhage.Narrative The successful accomplishment of the objectives of this proposal would elucidate age related changes in mitochondrial gene expression in the heart after trauma-hemorrhage and the gene chip that will be developed as part of this project will have a broader use in aging and cardiovascular research.